RE:With any luck...MM - you've listed all the things that NOW make this worth far more than the $0.80 per share when Baxter first came on board. Dialco has achieved all it needs to with only DIMI approval to come ("when not if"). AND now that PMX has the Breakthrough Designation it wouldn't surprise me if Baxter moves to acquire the technology now rather than waiting.
Shame they never explained the "Reimbursement - Breakthrough designation" in the AGM presentation. Does this mean Spectral can expect reimbursement from Baxter for costs? If so this likely wipes out any need for a raise of funds. And if options are exercised before the price gets too high (capital gain treatment instead of fully taxed) there'll be more funds in the kitty. Guess we'll have to wait for our crack disclosure team to explain what "reimbursement" means.
In any case looks like the requisite achievements for the end game are upon us....